Does Quartz Health Solutions Cover Lipitor?

At a glance
- Generic name / atorvastatin calcium, 10 mg to 80 mg tablets
- Typical formulary tier / Tier 1 (preferred generic) for atorvastatin
- Brand-name Lipitor tier / Tier 3 or non-formulary on most Quartz plans
- Estimated generic copay / $5 to $15 per 30-day fill
- Prior authorization for generic / not typically required
- Step therapy / may apply if requesting brand when generic is available
- Quantity limits / generally 30 tablets per 30 days
- Mail-order option / 90-day supply available at reduced cost
- Quartz plan types that cover statins / HMO, POS, and marketplace (ACA) plans
- Recommended action / verify your specific formulary at quartz.net or call member services
How Quartz Health Solutions Handles Statin Coverage
Quartz Health Solutions, a Wisconsin-based insurer offering HMO, POS, and ACA marketplace plans, includes atorvastatin on its prescription drug formulary. Generic atorvastatin sits on the lowest-cost tier for the vast majority of Quartz members. This follows the broader industry pattern: nearly all commercial insurers cover generic statins without restrictions because cardiovascular disease prevention guidelines strongly recommend them.
Why Generic Atorvastatin Gets Preferred Status
The 2018 ACC/AHA Cholesterol Guideline identifies high-intensity statins (atorvastatin 40 to 80 mg, rosuvastatin 20 to 40 mg) as first-line therapy for patients with established atherosclerotic cardiovascular disease (ASCVD) and for primary prevention in adults with LDL-C at or above 190 mg/dL [1]. Because clinical guidelines designate atorvastatin as a cornerstone drug, payers have a strong incentive to keep the generic on a preferred tier. Atorvastatin lost patent exclusivity in 2011, and its average wholesale price has dropped below $0.15 per tablet for most strengths.
Brand-Name Lipitor: A Different Tier
Brand-name Lipitor, manufactured by Viatris (formerly Pfizer's upjohn division), typically lands on Tier 3 (preferred brand) or may be excluded entirely from Quartz formularies. Patients who specifically request brand Lipitor should expect a copay between $45 and $100, and Quartz may require documentation that the generic is medically inappropriate before approving the brand.
Understanding Your Quartz Formulary Tier
Your actual out-of-pocket cost depends on which Quartz plan you carry, where atorvastatin falls on that plan's formulary, and whether you have met your deductible. Most Quartz formularies use a four- or five-tier structure, and atorvastatin almost always occupies the lowest tier.
Tier Structure Breakdown
Quartz typically organizes drug tiers as follows:
| Tier | Category | Typical Copay Range | |------|----------|-------------------| | 1 | Preferred generic | $5 to $15 | | 2 | Non-preferred generic | $15 to $30 | | 3 | Preferred brand | $45 to $75 | | 4 | Non-preferred brand | $75 to $150 | | 5 | Specialty | 20% to 33% coinsurance |
Generic atorvastatin falls on Tier 1 in most Quartz plan designs. That means it carries the lowest possible copay, and the drug is available without prior authorization or step therapy hurdles.
ACA Preventive Statin Coverage
Under the Affordable Care Act, statins prescribed for primary ASCVD prevention in adults aged 40 to 75 with one or more cardiovascular risk factors must be covered with zero cost-sharing when the prescription aligns with the USPSTF Grade B recommendation [2]. This applies to all Quartz marketplace and ACA-compliant plans. If your clinician prescribes atorvastatin specifically for primary prevention and you meet the USPSTF criteria, you may owe nothing at the pharmacy counter.
Clinical Evidence Supporting Atorvastatin
Atorvastatin is one of the most extensively studied drugs in cardiovascular medicine. Payers like Quartz rely on this evidence base to justify formulary placement. Here are the landmark trials that built the case.
Primary Prevention Data
The ASCOT-LLA trial (N=10,305) demonstrated that atorvastatin 10 mg reduced the primary endpoint of nonfatal myocardial infarction and fatal coronary heart disease by 36% compared with placebo (hazard ratio 0.64, 95% CI 0.50 to 0.83, P=0.0005) in hypertensive patients with average cholesterol levels [3]. The trial was stopped 2 years early because the benefit was so clear. The CARDS trial (N=2,838) found a 37% reduction in major cardiovascular events with atorvastatin 10 mg in patients with type 2 diabetes, again halted early for efficacy [4].
Secondary Prevention and High-Intensity Dosing
The TNT trial (N=10,001) compared atorvastatin 80 mg against atorvastatin 10 mg in patients with stable coronary disease. High-dose atorvastatin reduced the primary endpoint (major cardiovascular events) by 22% (HR 0.78, 95% CI 0.69 to 0.89, P<0.001) [5]. Dr. John LaRosa, the lead TNT investigator, noted: "Intensive lipid lowering with 80 mg of atorvastatin provided significant clinical benefit beyond that afforded by treatment with 10 mg in patients with stable CHD."
The PROVE IT-TIMI 22 trial (N=4,162) compared atorvastatin 80 mg with pravastatin 40 mg after acute coronary syndromes. Atorvastatin 80 mg reduced the composite endpoint by 16% (P=0.005), establishing the "lower is better" principle for LDL-C in high-risk patients [6].
What This Means for Quartz Members
Because atorvastatin has Grade A evidence for secondary prevention and Grade B evidence for primary prevention, Quartz (and essentially every other insurer) treats it as a must-cover drug. The clinical rationale and the low generic price align perfectly, which is why you are unlikely to encounter any access barrier.
How to Verify Your Specific Coverage
Even though generic atorvastatin is covered on virtually all Quartz plans, individual benefit designs can vary. Copay amounts, deductible structures, and pharmacy network restrictions differ across Quartz HMO, POS, and marketplace products. Take these steps to confirm your exact benefit.
Step 1: Check the Online Formulary
Log in to the Quartz member portal at quartz.net. Manage to "Pharmacy Benefits" or "Drug Formulary." Search for "atorvastatin" to see the tier, any quantity limits, and whether prior authorization applies.
Step 2: Call Member Services
The phone number on the back of your Quartz ID card connects you to a benefits specialist who can confirm your copay, tell you whether your deductible applies, and clarify if the ACA zero-cost-sharing preventive benefit covers your specific prescription.
Step 3: Ask Your Pharmacist
Pharmacists can run a real-time claims adjudication test at the counter. This tells you the exact dollar amount Quartz will charge before you commit to filling the prescription.
Reducing Your Out-of-Pocket Cost
Even with Quartz coverage, several strategies can lower your atorvastatin expense to zero or close to it.
Use Mail-Order Pharmacy
Quartz offers a mail-order pharmacy option for maintenance medications. A 90-day atorvastatin supply through mail order often costs the equivalent of two monthly copays (roughly $10 to $20 for three months), saving you one copay cycle per quarter.
Apply the ACA Preventive Benefit
If you are between 40 and 75 years old, have at least one ASCVD risk factor (hypertension, diabetes, dyslipidemia, smoking), and your clinician prescribes the statin specifically for primary prevention, the USPSTF statin recommendation triggers zero cost-sharing under ACA Section 2713 [2]. Ask your prescriber to include the appropriate ICD-10 and Z-code on the prescription to ensure the pharmacy processes it as preventive.
Consider Manufacturer and Pharmacy Discount Programs
While brand Lipitor coupons rarely apply to generics, some pharmacy chains offer atorvastatin on $4 or $0 generic lists. If your Quartz copay exceeds what the pharmacy charges cash-pay customers, ask the pharmacist to compare prices. The FDA Orange Book lists all approved generic atorvastatin manufacturers, confirming broad availability across multiple suppliers [7].
When Quartz Might Deny or Restrict Coverage
Denials for generic atorvastatin are rare, but not impossible. Understanding the scenarios where Quartz might push back helps you prepare.
Brand-Name Requests
If your prescriber writes "Lipitor" with "dispense as written" (DAW), Quartz may deny the claim or apply a much higher copay. The plan will generally require a letter from your physician explaining why the generic is not appropriate (for example, a documented allergy to an inactive ingredient in the generic formulation). The FDA considers generic atorvastatin bioequivalent to brand Lipitor under its ANDA approval process [8].
Quantity Limit Overrides
Quartz may impose a quantity limit of 30 tablets per 30-day fill for atorvastatin. Patients taking atorvastatin twice daily (uncommon but occasionally prescribed in combination protocols) would need a quantity limit override, which requires a prior authorization request from the prescriber.
High-Dose Justification
Some plans flag atorvastatin 80 mg fills for utilization review, especially in primary prevention patients. The 2018 ACC/AHA guideline recommends high-intensity therapy (atorvastatin 40 to 80 mg) for patients with clinical ASCVD, LDL-C of 190 mg/dL or above, or diabetes with multiple risk factors [1]. If your plan questions the 80 mg dose, your prescriber can cite the specific guideline indication.
Atorvastatin Safety Profile for Quartz Members
Quartz members starting atorvastatin should be aware of the drug's well-characterized safety profile.
Common Side Effects
Muscle-related symptoms (myalgia) occur in approximately 5% to 10% of statin users according to observational studies, though the SAMSON trial (N=60) demonstrated that 90% of statin-attributed muscle symptoms occurred equally on placebo, suggesting a large nocebo component [9]. A 2022 Lancet meta-analysis of 23 randomized trials (N=154,664) found that statins caused muscle pain or weakness in only about 1 in 15 patients over 5 years beyond what placebo caused [10].
Liver Monitoring
The 2012 FDA safety communication removed the requirement for routine periodic liver function tests for patients on statins [11]. Baseline liver enzymes before starting therapy remain standard practice, but repeated monitoring is necessary only if symptoms of hepatotoxicity develop (unexplained fatigue, appetite loss, dark urine, jaundice).
Drug Interactions to Flag
Atorvastatin is metabolized by CYP3A4. Quartz members should alert their prescriber if they take strong CYP3A4 inhibitors including clarithromycin, itraconazole, or HIV protease inhibitors, as these combinations increase atorvastatin exposure and myopathy risk. The ACC/AHA guideline recommends dose adjustment or statin switching in these situations [1].
Comparing Atorvastatin to Other Statins on Quartz Formularies
Quartz covers multiple statins, and your clinician may recommend alternatives depending on your lipid goals and tolerability.
Rosuvastatin (Crestor Generic)
Rosuvastatin is the other high-intensity statin option. The JUPITER trial (N=17,802) showed rosuvastatin 20 mg reduced the primary endpoint by 44% in patients with elevated hs-CRP and LDL-C below 130 mg/dL [12]. Generic rosuvastatin also sits on Tier 1 of most Quartz formularies.
Simvastatin and Pravastatin
These moderate-intensity statins are appropriate for patients who need less aggressive LDL lowering. Both are available as Tier 1 generics on Quartz plans, often at the same copay as atorvastatin.
Switching Between Statins
If you experience side effects on atorvastatin, your prescriber can switch to a different statin without requiring prior authorization from Quartz, as long as the replacement is also a Tier 1 generic. A dose equivalency table from the 2018 ACC/AHA guideline helps clinicians select the appropriate potency match [1].
Frequently asked questions
›Does Quartz Health Solutions cover Lipitor?
›Do I need prior authorization for atorvastatin on Quartz?
›Can I get atorvastatin for free on my Quartz plan?
›What tier is atorvastatin on the Quartz formulary?
›How much does atorvastatin cost with Quartz insurance?
›Does Quartz cover atorvastatin 80 mg?
›Can I use mail-order pharmacy for atorvastatin on Quartz?
›What if Quartz denies my Lipitor prescription?
›Does Quartz cover other statins besides atorvastatin?
›Is atorvastatin the same as Lipitor?
›How do I check my Quartz formulary for atorvastatin?
›Does Quartz require step therapy for statins?
References
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625
- US Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication. 2022. https://www.uspstf.org/recommendation/statin-use-in-adults-preventive-medication
- Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial, Lipid Lowering Arm (ASCOT-LLA). Lancet. 2003;361(9364):1149-1158. https://pubmed.ncbi.nlm.nih.gov/12686036/
- Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). Lancet. 2004;364(9435):685-696. https://pubmed.ncbi.nlm.nih.gov/15325833/
- LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease (TNT). N Engl J Med. 2005;352(14):1425-1435. https://pubmed.ncbi.nlm.nih.gov/15755765/
- Cannon CP, Braunwald E, Murphy SA, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes (PROVE IT-TIMI 22). N Engl J Med. 2004;350(15):1495-1504. https://pubmed.ncbi.nlm.nih.gov/15007110/
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- U.S. Food and Drug Administration. What Are Generic Drugs? https://www.fda.gov/drugs/generic-drugs/what-are-generic-drugs
- Wood FA, Howard JP, Finegold JA, et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects (SAMSON). N Engl J Med. 2020;383(22):2182-2184. https://pubmed.ncbi.nlm.nih.gov/33165530/
- Cholesterol Treatment Trialists' Collaboration. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet. 2022;400(10355):832-845. https://pubmed.ncbi.nlm.nih.gov/36049498/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs. 2012. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008;359(21):2195-2207. https://pubmed.ncbi.nlm.nih.gov/18997196/